HAGH and prostate cancer: More recently, we demonstrated that Glo2 is regulated also by PTEN/PI3K/AKT/mTOR signaling via pyruvate kinase (PK)M2-mediated estrogen receptor alpha (ERα) activation as a novel mechanism to drive prostate cancer (PCa) progression [31].